References
- Smith L.J., McCulloch E.A., Benchimol S. Expression of the p53 oncogene in acute myeloblastic leukemia. J. Exp. Med. 1986; 164: 751–761
- McCulloch E.A., Till J.E. Blast cells in acute myeloblastic leukemia: a model. Blood Celts 1981; 7: 63–77
- McCulloch E.A., Kelleher C.A., Miyauchi J. Heterogeneity in acute myeloblastic leukemia. Leukemia 1988; 3: 385–495
- Lange B., Valtieri M., Santoli D. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood 1987; 70: 192–199
- Hoang T., McCulloch E.A. Production of leukemic blast growth factor by a human bladder carcinoma cell line. Blood 1985; 66: 748–751
- Buick R.N., Minden M.D., McCulloch E.A. Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. Blood 1979; 54: 95–104
- Vu H., Hirshbein B. Internucleotide phosphite sulfurization with tetraethylthiuram disulfide. Tetrahedren Lett. 1991; 32: 3005–3008
- Fritz H.J., Belagaje R., Brown E. PPLC in polynucleotide synthesis. Biochemistry 1978; 17: 1257–1267
- Becker C.R., Efcavitch J.W., Heiner C.R., Kaiser N.F. Use of a reverse phase column for the HPLC purification of synthetic oligonucleotides. J. Chromatogr. 1985; 326: 293–299
- Ronen D., Rotter V., Reisman D. Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif. Proc. Natl. Acad. Sci. USA 1991; 88: 4128–4132
- Anfossi G., Gewirtz A.M., Calabretta B. An oligomer complementary to C-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc. Natl. Acad. Sci. USA 1989; 86: 3379–3383
- Wolf D., Rotter V. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc. Natl. Acad. Sci. USA 1985; 82: 790–794
- Pike P.L., Robinson W.A. Human bone marrow colony growth in agar-gel. J. Cell Physiol. 1970; 76: 77.6
- Curtis J.E., Messner H.A., Hasselback R. Contributions of host- and disease-related attributes to the outcome of patients with acute myelogenous leukemia. J. Clin. Oncol. 1984; 2: 253–260
- Kastan M.B., Radin A.I., Kuerbitz S.J. Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer. Res. 1991; 51: 4279–4286
- Rivas C.I., Wisniewski D., Strife A. Constitutive expression of p53 protein in enriched normal human marrow blast populations. Blood 1992; 79: 1982–1986
- Mercer W.E., Baserga R. Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes. Exp. Cell Res. 1985; 160: 31–46
- Levine A.J., Momand J., Finlay C.A. The p53 tumor suppressor gene. Nature 1991; 351: 453–456
- Lane D.P. p53, guardian of the genome. Nature 1992; 358: 15–16
- Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science 1991; 253: 49–53
- Sugimoto K., Toyoshima H., Sakai R. Mutations of the p53 gene in lymphoid leukemia. Blood 1991; 77: 1153–1156
- Slingerland J.M., Minden M.D., Benchimol S. Mutation of p53 in human acute myelogenous leukemia. Blood 1991; 77: 1500–1507
- Hu G., Zhang W., Deisseroth A.B. p53 gene mutations in acute myelogenous leukaemia. Br. J. Haematol. 1992; 81: 489–494
- Fenaux P., Jonveaux P., Quiquandon I., Lai J.L. p53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 1991; 78: 1652–1657
- Zhang W., Hu G., Estey E., Hester J., Deisseroth A. Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells. Oncogene 1992; 7: 1645–1647
- Barnes D.M., Hanby A.M., Gillett C.E. Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet 1992; 340: 259–263